Skip to content

Life Sciences Expansion in Europe Starts in Switzerland

health-dna

Switzerland is home to a thriving health innovation ecosystem, with access to global leaders in medtech, biotech, and pharma. Companies benefit from:

  • Proximity to top-tier hospitals, universities, and R&D centers
  • Predictable regulatory pathways for clinical development
  • Skilled multilingual professionals across the value chain

Why Switzerland for Life Sciences?

  • R&D Hub – Tap into top-tier talent and collaborative networks across universities, hospitals, and industry. Swissmedic’s streamlined approvals align with EMA and FDA standards, easing global regulatory paths.
  • IP & Incentives – Protect your innovation with strong IP laws and benefit from R&D tax incentives like patent boxes and innovation deductions, all within a stable regulatory environment.
  • Regional HQ – Launch and coordinate clinical and commercial activities from a central base. Switzerland’s tax structure, specialized talent, and proximity to EU markets make it a leading choice for biotech HQs.
  • Manufacturing – Build with confidence in a market known for precision, talent, and “Swiss Made” quality. Benefit from integrated logistics, including cold chain and rapid access to EU markets.
  • Supplier Network – Access a deep bench of specialized suppliers, CDMOs, CROs, and labs, all within a compact, highly connected country built for speed and scale.

Whether you're testing, scaling, or manufacturing, we help you take your next step to health innovation in Switzerland.

Success Stories

From Boston to Basel: LifeMine selects Switzerland for next frontier drug discovery

For the renowned scientist and multi-entrepreneur Greg Verdine, the Basel Area is more than just a geographical location – it represents a thriving hub for life sciences and innovation that rivals...

Read More

Incyte, a key player in Western Switzerland’s biopharmaceutical innovation landscape

From clinical research to international leadership, Incyte’s steady growth in Western Switzerland showcases the region’s strength in biopharmaceutical innovation.

Read More

Merck: “Switzerland Offers Attractive and Stable Conditions for International Companies.”

Science and technology leader Merck has been in Switzerland for almost a century. Today it has eight sites, including five manufacturing facilities, and in the last two years the company has invested...

Read More